Cargando…
Nivolumab-induced alopecia areata: A reversible factor of good prognosis?
Autores principales: | Lakhmiri, Myriam, Cavelier-Balloy, Bénédicte, Lacoste, Caroline, Cassius, Charles, Baroudjian, Barouyr, Delyon, Julie, Lebbé, Céleste, Reygagne, Pascal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6141643/ https://www.ncbi.nlm.nih.gov/pubmed/30246120 http://dx.doi.org/10.1016/j.jdcr.2018.05.022 |
Ejemplares similares
-
Yield of FDG PET/CT for Defining the Extent of Disease in Patients with Kaposi Sarcoma
por: Pesqué, Louise, et al.
Publicado: (2022) -
Sonidegib in the Treatment of Locally Advanced Basal Cell Carcinoma: A Retrospective Study
por: HERMS, Florian, et al.
Publicado: (2022) -
18FDG PET Assessment of Therapeutic Response in Patients with Advanced or Metastatic Melanoma Treated with First-Line Immune Checkpoint Inhibitors
por: Rivas, Alexia, et al.
Publicado: (2022) -
When steroids are not enough in immune-related hepatitis: current clinical challenges discussed on the basis of a case report
por: Gauci, Marie-Léa, et al.
Publicado: (2021) -
Clinico-dermoscopic features of alopecia areata in patients with psoriasis
por: Tassone, Francesco, et al.
Publicado: (2018)